These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 37047549)

  • 21. Is there a role for estrogen replacement therapy in the prevention and treatment of dementia?
    Birge SJ
    J Am Geriatr Soc; 1996 Jul; 44(7):865-70. PubMed ID: 8675940
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Menopause and cognitive complaints: are ovarian hormones linked with subjective cognitive decline?
    Reuben R; Karkaby L; McNamee C; Phillips NA; Einstein G
    Climacteric; 2021 Aug; 24(4):321-332. PubMed ID: 33719785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is Early Menopause a Different Entity From Premature Ovarian Insufficiency?
    Anagnostis P; Lambrinoudaki I; Goulis DG
    Clin Endocrinol (Oxf); 2024 Sep; ():. PubMed ID: 39279431
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oophorectomy, menopause, estrogen treatment, and cognitive aging: clinical evidence for a window of opportunity.
    Rocca WA; Grossardt BR; Shuster LT
    Brain Res; 2011 Mar; 1379():188-98. PubMed ID: 20965156
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Premature ovarian insufficiency and neurological function.
    Soni M; Hogervorst E
    Minerva Endocrinol; 2014 Sep; 39(3):189-99. PubMed ID: 24942013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Menopausal Hormone Therapy and Cardiovascular Risk: Where are we Now?
    Anagnostis P; Paschou SA; Katsiki N; Krikidis D; Lambrinoudaki I; Goulis DG
    Curr Vasc Pharmacol; 2019; 17(6):564-572. PubMed ID: 29984659
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hormone therapy in the postmenopausal years: considering benefits and risks in clinical practice.
    Genazzani AR; Monteleone P; Giannini A; Simoncini T
    Hum Reprod Update; 2021 Oct; 27(6):1115-1150. PubMed ID: 34432008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oophorectomy, estrogen, and dementia: a 2014 update.
    Rocca WA; Grossardt BR; Shuster LT
    Mol Cell Endocrinol; 2014 May; 389(1-2):7-12. PubMed ID: 24508665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Premature ovarian insufficiency: the need for evidence on the effectiveness of hormonal therapy.
    Upton CE; Daniels JP; Davies MC
    Climacteric; 2021 Oct; 24(5):453-458. PubMed ID: 33928827
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON MENOPAUSE-2017 UPDATE.
    Cobin RH; Goodman NF;
    Endocr Pract; 2017 Jul; 23(7):869-880. PubMed ID: 28703650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bone health in women with premature ovarian insufficiency/early menopause: a 23-year longitudinal analysis.
    Jones AR; Enticott J; Ebeling PR; Mishra GD; Teede HT; Vincent AJ
    Hum Reprod; 2024 May; 39(5):1013-1022. PubMed ID: 38396142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Menopause and cognitive impairment: A narrative review of current knowledge.
    Conde DM; Verdade RC; Valadares ALR; Mella LFB; Pedro AO; Costa-Paiva L
    World J Psychiatry; 2021 Aug; 11(8):412-428. PubMed ID: 34513605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early menopause and premature ovarian insufficiency are associated with increased risk of dementia: A systematic review and meta-analysis of observational studies.
    Karamitrou EK; Anagnostis P; Vaitsi K; Athanasiadis L; Goulis DG
    Maturitas; 2023 Oct; 176():107792. PubMed ID: 37393661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. European Menopause and Andropause Society (EMAS) and International Gynecologic Cancer Society (IGCS) position statement on managing the menopause after gynecological cancer: focus on menopausal symptoms and osteoporosis.
    Rees M; Angioli R; Coleman RL; Glasspool R; Plotti F; Simoncini T; Terranova C
    Maturitas; 2020 Apr; 134():56-61. PubMed ID: 32059825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alzheimer's disease, apolipoprotein E and hormone replacement therapy.
    Depypere H; Vierin A; Weyers S; Sieben A
    Maturitas; 2016 Dec; 94():98-105. PubMed ID: 27823753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of endogenous and exogenous estrogen exposures in midlife and late-life women on episodic memory and executive functions.
    Henderson VW; Popat RA
    Neuroscience; 2011 Sep; 191():129-38. PubMed ID: 21664950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hormone Replacement Therapy and Alzheimer's Disease: Current State of Knowledge and Implications for Clinical Use.
    Sayfullaeva J; McLoughlin J; Kwakowsky A
    J Alzheimers Dis; 2024; 101(s1):S235-S261. PubMed ID: 39422965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alzheimer's disease: review of hormone therapy trials and implications for treatment and prevention after menopause.
    Henderson VW
    J Steroid Biochem Mol Biol; 2014 Jul; 142():99-106. PubMed ID: 23727128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estrogen: a neuroprotective or proinflammatory hormone? Emerging evidence from reproductive aging models.
    Sohrabji F
    Ann N Y Acad Sci; 2005 Jun; 1052():75-90. PubMed ID: 16024752
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The nature of the effect of female gonadal hormone replacement therapy on cognitive function in post-menopausal women: a meta-analysis.
    Hogervorst E; Williams J; Budge M; Riedel W; Jolles J
    Neuroscience; 2000; 101(3):485-512. PubMed ID: 11113299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.